首页> 外文期刊>JAMA: the Journal of the American Medical Association >Research opportunities and advances in lung disease.
【24h】

Research opportunities and advances in lung disease.

机译:肺部疾病的研究机会和进展。

获取原文
获取原文并翻译 | 示例
       

摘要

Lung diseases cause morbidity, mortality, and economic burden. Susceptibility to pathogenesis of most lung diseases result from a complex interaction of a relevant challenge from the environment, genetic background, and the nature of the host responses. Cutting-edge research in lung disease now centers on understanding the lung as a genetically determined biological organ that functions to mediate gas exchange and defend against a hostile environment. A major challenge is to determine the hierarchy of gene expression that integrates the function of multiple cell types in this complex anatomy. Emerging therapies that will play a major role in the future treatment of lung disease include the use of recombinant proteins, including monoclonal antibodies, cell therapy (including stem cells), and gene therapy. Future advances will include the cure of the major hereditary lung disorders by gene therapy, new treatment for asthma, chronic obstructive pulmonary disease, and interstitial lung disease; development of vaccines to protect the lung from major lung pathogens; and pathogen-specific "designer" therapies to eradicate chronic lung infections.
机译:肺部疾病会导致发病,死亡和经济负担。大多数肺部疾病的发病易感性来自环境,遗传背景和宿主反应性质的相关挑战的复杂相互作用。现在,关于肺部疾病的前沿研究集中在理解肺部是一种遗传确定的生物器官,其功能是介导气体交换并防御恶劣的环境。一个主要的挑战是确定在复杂的解剖结构中整合多种细胞功能的基因表达层次。在肺部疾病的未来治疗中将起主要作用的新兴疗法包括重组蛋白的使用,包括单克隆抗体,细胞疗法(包括干细胞)和基因疗法。未来的进展将包括通过基因疗法治愈主要的遗传性肺部疾病,哮喘,慢性阻塞性肺病和间质性肺病的新疗法;开发保护肺免受主要肺病原体侵害的疫苗;以及根除病原体的“设计剂”疗法来根除慢性肺部感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号